LIFE SCIENCES ARTICLES

FROM THE TEAM AT ASHTON TWEED

LATEST LIFE SCIENCES ARTICLES

December 1, 2020

The Race for Safe Vaccines

By Lea Wolfinger, VP Ashton Tweed Research and development for safe, reliable vaccines is typically a lengthy process – as in many years. Enter COVID-19 and, […]
November 23, 2020

Leadership Insight for Life Sciences

“The led must not be compelled; they must be able to choose their own leader.”                 – Albert Einstein Leadership […]
November 16, 2020

 4 Keys to Bridging the Digital Talent Gap at C-Level

By James Rudman. In this era of continual technological advances, one of the top challenges facing Life Science, biotech, and many industries is an ever-growing digital […]
October 22, 2020

Drug Research and Development – Finding the Post-COVID Normal

By Jordan Warshafsky. By April, merely a few weeks after the pandemic onset, surveys were already indicating that nearly 50% of research labs worldwide were forced […]
July 31, 2020
life sciences funding

Life Sciences Fundraising in the Wake of COVID-19

By Jim Rudman, CEO, Ashton Tweed and Robert Dickey IV, Managing Director, Foresite Advisors, LLC See this article on LinkedIn. The coronavirus pandemic is just one […]
May 28, 2020
Female professional working with eclinical data.

Going Virtual – Embracing Change in Clinical Trials

By Jim Rudman, CEO, Ashton Tweed See this article on LinkedIn. When Ed Seguine, CEO of Clinical Ink, joined the company in 2010, he saw that […]
January 24, 2020
AI

AI in the Life Sciences – What’s all the Hype?

By Robert Ruth, Vice President & Managing Director, Ashton Tweed See this article on LinkedIn. The advancement and implementation of artificial intelligence (AI) has been a […]
November 18, 2019

Digital Health & Wearables Encourage Education & Prevention

By Jim Rudman, CEO, Ashton Tweed See this article on LinkedIn. An annual global survey conducted by the American College of Sports Medicine recently predicted that […]
September 3, 2019
Medical doctor working with modern computer interface

Navigating Uncharted Territory: Top Advice from 3 Digital Health CEOs

By Ashley Phillips, Director of Executive Recruitment, Ashton Tweed See this article on LinkedIn. Digital health companies are on the rise and medtech funding is increasing globally. […]
April 19, 2019
idea concept

Staying Focused in Today’s Exciting Life Science Industry

By Jim Rudman, CEO, Ashton Tweed See this article on LinkedIn. 3D printing, a technology invented by Charles Hull in the early 1980s, has been applied […]
July 20, 2018
Business leaders racing

Racing Against the Clock in the Life Sciences

By Jordan Warshafsky, Partner, Ashton Tweed See this article on LinkedIn. Time is of the essence in the life sciences industry, just as it is in […]
January 16, 2018
Business man looking out conference room window

Up Close and Personal with Uncertainty in the Life Sciences

By Jim Rudman, CEO, Ashton Tweed See this article on LinkedIn.   Life science leaders and entrepreneurs are familiar with the feeling of uncertainty and have […]
November 13, 2017
career transition concept

Why are Execs Leaving Big Pharma for Smaller Companies?

By Jordan Warshafsky, Partner, Ashton Tweed See this article on LinkedIn.   Once executives gain their skills and experience in larger organizations, many choose to transition […]
June 5, 2017
Executive listening to podcast

Top 5 Podcasts for Life Science Execs

By Lea Wolfinger, Vice President, Ashton Tweed See this article on LinkedIn.   Have some free time while traveling, commuting, or working out? Put it to […]
February 20, 2017
Ethics scale

5 Ways to Navigate Ethics in the Life Sciences

By Jordan Warshafsky, Partner, Ashton Tweed See this article on LinkedIn.   With gene editing clinical trials starting in humans and drug pricing taking center stage […]
close up of scientist writing test results in lab

WANT TO RECEIVE OUR ARTICLES VIA EMAIL?

SUBSCRIBE TO OUR NEWSLETTER

  • Put "N/A" if not applicable.

    Ashton Tweed Privacy Policy - Your information is kept confidential.
  • This field is for validation purposes and should be left unchanged.